SCHEMBL23732607

SCHEMBL23732607

CCN/N=C/c1cccc(OC)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRM5 P08912 1/20 0.62
▸ NPC1 O15118 3/20 0.52
▸ RAB9A P51151 3/20 0.52
▸ ALDH1A1 P00352 3/20 0.52
▸ TAAR1 Q96RJ0 1/20 0.51
▸ MAPT P10636 3/20 0.50
▸ MEN1 O00255 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ CYP1A2 P05177 1/20 0.50
▸ CYP3A4 P08684 1/20 0.50
▸ RECQL P46063 1/20 0.50
▸ TDP1 Q9NUW8 1/20 0.50
▸ HDAC6 Q9UBN7 1/20 0.50
▸ NPSR1 Q6W5P4 1/20 0.50
▸ G6PC1 P35575 1/20 0.50
▸ PKM P14618 1/20 0.48
▸ RELA Q04206 1/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ LMNA P02545 1/20 0.46
▸ TP53 P04637 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18757991 0.82 CHRM5 (0.55) CHRM5NPC1RAB9AALDH1A1TAAR1
SCHEMBL23732714 0.82 MAPT (0.56) CHRM5NPC1RAB9AALDH1A1MAPT
SCHEMBL25731888 0.81 CHRM5 (0.68) CHRM5NPC1RAB9AALDH1A1TAAR1
SCHEMBL25731885 0.80 CHRM5 (0.66) CHRM5NPC1RAB9AALDH1A1TAAR1
SCHEMBL19441389 0.79 ALDH1A1 (0.60) NPC1RAB9AALDH1A1MAPTMEN1
SCHEMBL1654602 0.77 CHRM5 (1.00) CHRM5NPC1TAAR1CYP1A2CYP3A4
SCHEMBL16224316 0.76 CHRM5 (0.60) CHRM5NPC1RAB9AALDH1A1TAAR1
SCHEMBL23996033 0.76 CHRM5 (0.60) CHRM5NPC1RAB9AALDH1A1TAAR1
SCHEMBL17560868 0.76 NPC1 (0.67) CHRM5NPC1RAB9AALDH1A1MAPT
SCHEMBL19449718 0.76 NPC1 (0.67) CHRM5NPC1RAB9AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3362448-B1 NEW COMPOUNDS INHIBITORS OF THE YAP/TAZ-TEAD INTERACTION AND THEIR USE IN THE TREATMENT OF MALIGNANT MESOTHELIOMA INVENTIVA (FR) 2021-08-04 — — EP disclosed
Send feedback